5 Written questions
5 Matching questions
- hat is the mininum number of seeds that must be deposited to be considered by the Office?
- a Requirements for Compliance, Statements Regarding New Matter, and Sanctions for Failure to Comply
- b Sequence Listing Numeric Identifiers
- c Need or Opportunity to Make a Deposit
37 CFR 1.802(a) permits a deposit of a biological material to be referenced in a patent application where an invention is, or relies on, a biological material. The invention may rely on a biological material for the purposes of making or using the invention, either as a preferred mode or an alternative mode of operation. A reference to a deposit may be included in a specification even though the deposit is not required to satisfy the requirements of 35 U.S.C. 112.
- d Conditions of Deposit
- e 2500
5 Multiple choice questions
- Certification of Statement of Availability of Deposit
- Possible Loss of U.S. Filing Date in Other Countries
caution that in many countries the deposit must be made before the filing date of the priority application in order to obtain foreign priority rights.
- Application in Condition for Allowance Except for Deposit
As set forth in 37 CFR 1.809(c), in the event that an application for patent is otherwise in condition for allowance except for a required deposit and the Office has received a written assurance that an acceptable deposit will be made, applicant will be notified and given a period of time within which the deposit must be made in order to avoid abandonment of the application for failure to prosecute the application under 35 U.S.C. 133
- Treatment of Replacement
37 CFR 1.805(e)
where a replacement deposit is permitted and made, the examiner will assume that the same material as described in the patent is accessible from the identified depository unless evidence to the contrary comes to the attention of the Office
- Additional Miscellaneous Requirements
5 True/False questions
2421.01 → Application Affected
The sequence rules require the use of standard symbols and a standard format for sequence data in most sequence-type patent applications. They further require the submission of that data in computer readable form. Compliance is required for most disclosures of sequence data in new applications filed on or after October 1, 1990.
2422.02 → Definitions of Nucleotide and/or Amino Acids for Purpose of Sequence Rules
2421.04 → After Patent Has Been Granted
2427.01 → Form Paragraphs
2411 → Overview of the Sequence Rules